National use of postmenopausal hormone therapy: annual trends and response to recent evidence.
about
Progestin effects on cell proliferation pathways in the postmenopausal mammary glandRecent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtypeDifferences in menopausal hormone therapy use among women in Germany between 1998 and 2003Exercise for vasomotor menopausal symptomsPrinted educational materials: effects on professional practice and healthcare outcomesBioidentical hormones for women with hot flushesExercise for vasomotor menopausal symptomsExercise for vasomotor menopausal symptomsExercise for vasomotor menopausal symptomsPartisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy.Use of prescription and over-the-counter medications and dietary supplements among older adults in the United StatesChanges in postmenopausal hormone replacement therapy use among women with high cardiovascular riskEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Increased cardiovascular mortality after early bilateral oophorectomyChanges in elderly women's health-related quality of life following discontinuation of hormone replacement therapy.Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive reviewBioidentical hormones for women with vasomotor symptomsComparative effectiveness research and its utility in In-clinic practiceTowards understanding the de-adoption of low-value clinical practices: a scoping reviewMigraine in women: the role of hormones and their impact on vascular diseasesOophorectomy, estrogen, and dementia: a 2014 updateBody mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor statusMenopausal hormone therapy and breast cancer mortality: clinical implicationsPrescribing menopausal hormone therapy: an evidence-based approachMolecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of PremarinBioidentical hormone therapyAverage household exposure to newspaper coverage about the harmful effects of hormone therapy and population-based declines in hormone therapy useDiscovering Multi-Scale Co-Occurrence Patterns of Asthma and Influenza with Oak Ridge Bio-Surveillance ToolkitRetrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States borderAbsolute configurations of DNA lesions determined by comparisons of experimental ECD and ORD spectra with DFT calculationsAssociation Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk.New evidence for cardiac benefit of postmenopausal hormone therapy.Mind-body therapies for menopausal symptoms: a systematic review.Depression or menopause? Presentation and management of major depressive disorder in perimenopausal and postmenopausal women.Medroxyprogesterone acetate impairs memory and alters the GABAergic system in aged surgically menopausal rats.The cognitive effects of conjugated equine estrogens depend on whether menopause etiology is transitional or surgical.Separation of dansylated 17β-estradiol, 17α-estradiol, and estrone on a single HPLC column for simultaneous quantitation by LC-MS/MS.Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.Exploring the continuum: medical information to effective clinical practice. Paper I: the translation of knowledge into clinical practice.Hormone therapy after the Women's Health Initiative: a qualitative study.
P2860
Q21092903-D5F34E7F-619E-4E55-ABBA-14A12478FAFBQ21195226-7CBCC2BD-8FB7-486D-AA40-2EB2919D4A47Q21254698-AB0B736C-5FCB-42F6-BF9B-E31F345D2495Q24187786-96C7A43D-64A3-44E6-80F4-D23F95A8C96CQ24198184-F0048819-46B6-4F81-B292-5EF162AAAEADQ24201312-28FFB4AC-2457-49C1-B194-3C0871938C94Q24234440-CDE58C27-0838-4DE6-9D23-81BEA9454BB5Q24243116-D17C4E41-9A33-40E2-9D23-637EF6BEBAB4Q24245931-6776AEFA-119F-4A0D-AE02-303A59DA1258Q24289488-2B5C9C92-5D58-4D06-8522-6015297667F1Q24657307-6D3F16E7-CCA2-468C-AF76-83C85E3ADFB2Q24658107-E49C66EC-93BB-4429-BE1A-1BBA16977365Q24658109-EED4F7B9-4B40-4505-8C03-7F3B074C28CDQ24658403-B4A77BC6-B51E-453F-9D09-E16790C016A2Q24814779-36710EE2-2157-4EC0-96AD-C8300BD2B192Q24815702-A54E5EF0-B407-4CF6-880E-E6D0FF62B601Q26470545-BDCF4429-8E08-447E-8C6F-D5AD90CAF698Q26767184-14A83EA1-BBD5-4D44-A8B6-1642C074BC5DQ26786656-3B641566-0AD4-4FC1-893F-4F3BA11B7FDFQ26853088-8CE20199-D2F5-48C9-A0D0-B12AEA2B88D6Q26853730-A8EE31E8-7986-4911-AEF1-019C2D18E45FQ27012792-E8C38F99-E20C-4710-9746-A2A1FED0E02FQ27022201-94CEE457-BB5A-443F-8001-48175775F30DQ27022920-C73CAE9C-FF07-42AA-8799-7FC997959751Q27648855-033B2D70-00C6-447C-8A43-EE3F42463910Q27691410-2DAF68FC-5938-4AAB-9D6F-EDEFB64FF14BQ28220662-39DD547E-817C-4089-8BCD-4CD71066FF47Q28384821-531B4AB5-C98F-4ABC-9AC2-7053ED973D5EQ28607512-F9B2904E-DD42-4063-933E-9166D2159AB7Q28659270-9467E5CD-6D35-4BE0-879F-A095290A177BQ30277016-3F90859A-F529-4E89-B28C-09FE88A96197Q30396979-3285565A-3F6A-4642-8210-75AFEBA9E87BQ30432169-67964C21-C5D7-46B9-8513-8B39337E8F54Q30435798-6828D77E-D947-4E26-9F3B-65E152C12489Q30465714-144C28FB-38C7-4B9F-8D5C-0DD0BE70C6AEQ30496612-C16B8E42-A21C-4108-97DC-DCD780554735Q30537737-63DEBE9A-209F-4BD2-A605-3B1C32C8644EQ31122463-42CD4305-2EA0-4543-8937-67735CB0D357Q33232047-2E1F9586-A04D-44D3-B8F1-69E397947FEDQ33261267-E709DF54-E0C5-4A6C-9A28-F4087AE16690
P2860
National use of postmenopausal hormone therapy: annual trends and response to recent evidence.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
National use of postmenopausal ...... d response to recent evidence.
@ast
National use of postmenopausal ...... d response to recent evidence.
@en
National use of postmenopausal ...... d response to recent evidence.
@nl
type
label
National use of postmenopausal ...... d response to recent evidence.
@ast
National use of postmenopausal ...... d response to recent evidence.
@en
National use of postmenopausal ...... d response to recent evidence.
@nl
prefLabel
National use of postmenopausal ...... d response to recent evidence.
@ast
National use of postmenopausal ...... d response to recent evidence.
@en
National use of postmenopausal ...... d response to recent evidence.
@nl
P2093
P356
P1476
National use of postmenopausal ...... d response to recent evidence.
@en
P2093
Adam L Hersh
Marcia L Stefanick
Randall S Stafford
P356
10.1001/JAMA.291.1.47
P407
P577
2004-01-01T00:00:00Z